Inflammation-Based Prognostic Score Predicts Postoperative Survival of Patients with Interstitial Pneumonia After Undergoing Lung Cancer Resection. 2018

Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
Department of General Thoracic Surgery, Dokkyo Medical University, Mibu, Japan.

Idiopathic interstitial pneumonias (IIPs) are associated with an increased risk of lung cancer. Glasgow prognostic score (GPS), which uses serum C-reactive protein (CRP) and albumin levels to indicate systemic inflammatory response and nutrition level, has been reported to be a predictor of overall survival in patients with various types of cancer. We evaluated the usefulness of GPS for prediction of survival of patients with both lung cancer and IIPs following a lung resection procedure. Patients with IIPs who underwent lung cancer resection from January 2006 through December 2015 were investigated. Routine laboratory measurements, including serum CRP and albumin for determining GPS, were performed before the operation. Univariate and multivariate analyses with a COX proportional hazards regression model were used to identify independent risk factors for overall survival (OS), relapse-free survival (RFS), cancer-specific survival (CSS), and other disease-specific survival (ODSS). A total of 135 patients underwent lung resection during the study period. Multivariate analysis selected sublobar resection (p = 0.035), UIP pattern (p = 0.025), and GPS of 1-2 (p = 0.042) as predictive factors associated with OS, while GPS of 1-2 (p = 0.039) was shown to be a predictive factor associated with RFS. Multivariate analysis also revealed pTNM (p < 0.001), usual interstitial pneumonia pattern (p = 0.006), and GPS of 2 (p = 0.003) as predictive factors associated with CSS, while univariate analysis indicated pTNM (p = 0.042), GPS of 1 (p = 0.044), and %DLCO (p = 0.038) as predictive factors associated with ODSS. GPS is an independent prognostic factor of OS and RFS in lung cancer patients with IIPs undergoing a lung resection procedure. Furthermore, a GPS of 2 was found to be associated with CSS following lung cancer resection, while a score of 1 was associated with ODSS.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011013 Pneumonectomy The excision of lung tissue including partial or total lung lobectomy. Bronchoscopic Lung Volume Reduction,Endoscopic Lung Volume Reduction,Lung Volume Reduction,Lung Volume Reduction Surgery,Partial Pneumonectomy,Partial Pneumonectomies,Pneumonectomies,Pneumonectomy, Partial,Reduction, Lung Volume,Volume Reduction, Lung
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
January 2021, International journal of general medicine,
Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
August 2010, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
January 2019, Journal of Cancer,
Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
January 2022, Frontiers in surgery,
Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
February 2013, BMC cancer,
Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
May 1999, Kyobu geka. The Japanese journal of thoracic surgery,
Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
April 2019, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
December 2017, Cancer medicine,
Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
January 2015, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Satoru Kobayashi, and Yuji Matsumura, and Yoko Karube, and Morimichi Nishihira, and Takashi Inoue, and Osamu Araki, and Sumiko Maeda, and Masayuki Chida
August 2007, International journal of colorectal disease,
Copied contents to your clipboard!